Page last updated: 2024-10-20

pyridoxal and Cardiomyopathies

pyridoxal has been researched along with Cardiomyopathies in 1 studies

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Potáčová, A1
Adamcová, M1
Čajnáková, H1
Hrbatová, L1
Sterba, M1
Popelová, O1
Šimůnek, T1
Ponka, P1
Gersl, V1

Other Studies

1 other study available for pyridoxal and Cardiomyopathies

ArticleYear
Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents.
    Physiological research, 2007, Volume: 56, Issue:2

    Topics: Aldehydes; Animals; Cardiomyopathies; Cardiotonic Agents; Chronic Disease; Daunorubicin; Disease Mod

2007